Abstract
Leuprorelin (leuprolide) acetate, a highly active agonist of luteinizing hormone-releasing hormone (LH-RH) has been widely accepted as a representative agent utilizing drug delivery system. A single injection of this one-month or three-month depot provides persistent drug release, which has been applied to therapy in patients with prostate cancer, breast cancer, endometriosis, myoma uteri, and central precocious puberty. The profile of this drug from basic research to clinical application was reviewed. © 2003, THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Ohyama, C., & Kato, T. (2003). Drug delivery system in hormonal agents: Long-term release LH-RH agonist. Drug Delivery System, 18(5), 431–437. https://doi.org/10.2745/dds.18.431
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.